Optimizing Chronic Pain Treatment With Enhanced Neuroplastic Responsiveness

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

July 12, 2019

Study Completion Date

July 12, 2019

Conditions
PainOsteoarthritis
Interventions
OTHER

Glucose Administration

For sessions 2 through 4, participants will fast for two hours prior to each session and consume 25-30 g of glucose at the start of each session.

OTHER

Intermittent Fasting

For sessions 2 through 4, participants will fast for 16 hours prior to the session (no food or beverages other than non-caloric beverages or coffee after 6 or 7 pm the evening prior).

OTHER

Control

Normal food intake

Trial Locations (1)

32611

Institute of Aging, Gainesville

All Listed Sponsors
collaborator

American Pain Society

OTHER

lead

University of Florida

OTHER

NCT02681081 - Optimizing Chronic Pain Treatment With Enhanced Neuroplastic Responsiveness | Biotech Hunter | Biotech Hunter